USPTO serial 99203362
EVOKE
Reviewed by CopyMark Law Group
Status 774
- Filing date
- Status date
- Registration date
- —
- Examiner
- ABID, NABEELA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with EVOKE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Scottsdale, AZ, US
Scottsdale, AZ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
PERRY GATTEGNO
PERRY GATTEGNO LITWIN KACH LLP401 N MICHIGAN, SUITE 1200CHICAGO, IL 60611UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biologics in the nature of pharmaceutical preparations for the treatment of chronic pain, inflammation, autoimmune diseases, and conditions benefiting from regenerative medicine being orthopedic and skin diseases and disorders, all for the purpose of accelerating healing and improvement of personal health and wellness; Pharmaceutical preparations for the treatment and prevention of chronic pain, inflammation, autoimmune diseases, and conditions benefiting from regenerative medicine in the nature of orthopedic and skin diseases and disorders, all for the purpose of accelerating healing and improvement of personal health and wellness; Pharmaceutical preparations for exosome treatments for medical purposes; Pharmaceutical preparations for treating chronic conditions in the nature of orthopedic and skin diseases and disorders and autoimmune diseases using exosomes for the purpose of accelerating healing and improvement of personal health and wellness; Biologics in the nature of cells for the treatment of chronic conditions being orthopedic and skin diseases and disorders and autoimmune diseases using exosomes and extracellular vesicles; Biological preparations for the treatment of chronic conditions in the nature of orthopedic and skin diseases and disorders and autoimmune diseases using exosomes and extracellular vesicles for the purpose of accelerating healing and improvement of personal health and wellness | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 29, 2026 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jun 29, 2026 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Jan 26, 2026 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Dec 30, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 30, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 24, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 2, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 2, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 2, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 2, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 2, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 24, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 24, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 24, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 14, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 14, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 14, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 14, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| May 27, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 27, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 27, 2025 | NWAP | NEW APPLICATION ENTERED | — |